April 27, 2015
RegMed’s mid-day: liquidity dries up with muted volume
April 25, 2015
RegMed, hit-or-miss proposition, with a lot more misses
April 24, 2015
RegMed’s mid-day: the substance of STEM’s offering, the shorts cover
April 22, 2015
RegMed’s equities no longer control their destiny
April 22, 2015
RegMed’s mid-day: twerking or twirling?
April 22, 2015
Capricor’s (CAPR) Duchenne Treatment gets FDA Orphan Drug Designation - SELL
April 21, 2015
RegMed’s holding on …
April 21, 2015
RegMed mid-day: Beavis versus Butt-head
April 17, 2015
RegMed’s aftershock and sell-off post Athersys (ATHX) miss
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2026 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.